par Cicor Technologies Ltd (isin : CH0008702190)
Cicor acquires Evolution Medtec Srl and strengthens its engineering capabilities in the Medtech sector
Cicor Technologies Ltd / Key word(s): Takeover Bronschhofen, February 28, 2024 - The Cicor Group (SIX Swiss Exchange: CICN) has acquired 100% of the shares of the Romanian engineering company Evolution Medtec Srl and is further expanding its engineering capabilities in the medical technology sector. Evolution Medtec is a provider of comprehensive engineering services with a strong focus on medical and paramedical applications. The company has been active in the development and prototyping of medtech applications for 20 years and currently employs 25 people in Bucharest, Romania. The FDA registered site is ISO 13485 certified. In the last fiscal year, Evolution Medtec generated sales in the lower single-digit million Euro range with an EBITDA margin comparable to the Cicor Group. Evolution Medtec's longstanding customers are medium and large medical device and industrial companies in Europe, the UK, and the US. Contact
The Cicor Group is a globally active provider of full-cycle electronic solutions from research and development to manufacturing and supply chain management. Cicor’s approximately 2,700 employees at 17 locations are serving leaders from the medical, industrial and aerospace & defence industries. Cicor creates value to its customers through the combination of customer-specific development solutions, high-tech components, as well as electronic device manufacturing. The shares of Cicor Technologies Ltd. are traded at the SIX Swiss Exchange (CICN). For further information, please visit the website www.cicor.com. End of Inside Information |
Language: | English |
Company: | Cicor Technologies Ltd |
c/o Cicor Management AG, Gebenloostraße 15 | |
9552 Bronschhofen | |
Switzerland | |
Phone: | +41719137300 |
Fax: | +41719137301 |
E-mail: | info@cicor.com |
Internet: | www.cicor.com |
ISIN: | CH0008702190 |
Valor: | 870219 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1846351 |
End of Announcement | EQS News Service |
1846351 28-Feb-2024 CET/CEST